Therapies for the future - Exploring solutions for innovative treatments in Europe

Register  
11-10-2017 14:00 - 17:15
European Parliament Brussels - Paul Henri Spaak (PHS) 7C050
L007458 300x200px.png

 

 

  Webstream available

 

 

 

 

Programme

 

 

Chair: Paul RÜBIG, MEP & STOA 1st Vice Chair
                      

14:30 – 15:00

  • Welcome
Paul RÜBIG, MEP & STOA 1st Vice Chair
 
  • Keynote speech
Vytenis ANDRIUKAITIS - European Commissioner for Health & Food Safety
 
  • Introduction
Beatrice LORENZIN - Italian Minister of Health
 

15:00 - 16:15  PART I – ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPs)

  • Moderator: Ilona G. REISCHL, Austrian Medicines and Medical Devices Agency
 
  • Guido RASI, European Medicines Agency

      Advanced therapy medicinal products: from promise to reality

 
  • Andrea CHIESI, European Biopharmaceutical Companies

      Advanced therapy medicinal products: the long journey from the unmet need to the patients

 
  • Line MATTHIESSEN-GUYADER, DG Research and Innovation

      Supporting research and innovation for advanced therapies

 
  • Yann LE CAM, European Organisation for Rare Diseases

      Now is the time to guarantee access to the therapies of the future

 
  • Q&A
 

16:15 - 17:10  PART II – NANOMEDICINE

  • Moderator: Elke ANKLAM, Joint Research Centre
 
  • Susanne BREMER-HOFFMANN Joint Research Centre

      Nanomedicine in EU: enabling innovative therapies

 
  • Patrick HUNZIKER, International Society for Nanomedicine

      Development in nanomedical clinics

 
  • Beat LOEFFLER, European Foundation for Clinical Nanomedicine 

      Nanomedicine at the international level

 
  • Q&A
 

17:10 - 17:15       CLOSING REMARKS

 
Paul RÜBIG, MEP & STOA 1st Vice Chair

 

 
 
  • URL